HERON THERAPEUTICS, INC. /DE/ (HRTX)
Nasdaq: HRTX · CIK 0000818033 · United States
Every official HERON THERAPEUTICS, INC. /DE/ filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open HRTX filings
HERON THERAPEUTICS, INC. /DE/ documents
- HERON THERAPEUTICS, INC. /DE/ 10-K 2026HRTX 10-K 2026: annual report for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ 10-K 2025HRTX 10-K 2025: annual report for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ 10-K 2024HRTX 10-K 2024: annual report for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ 10-K 2023HRTX 10-K 2023: annual report for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ 10-K 2022HRTX 10-K 2022: annual report for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ 10-Q 2026HRTX 10-Q 2026: quarterly report for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ 10-Q 2025HRTX 10-Q 2025: quarterly report for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ 10-Q 2024HRTX 10-Q 2024: quarterly report for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ 10-Q 2023HRTX 10-Q 2023: quarterly report for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ 10-Q 2022HRTX 10-Q 2022: quarterly report for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ 8-K 2026HRTX 8-K 2026: current report for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ 8-K 2025HRTX 8-K 2025: current report for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ 8-K 2024HRTX 8-K 2024: current report for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ 8-K 2023HRTX 8-K 2023: current report for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ 8-K 2022HRTX 8-K 2022: current report for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ DEF 14A 2026HRTX DEF 14A 2026: proxy statement for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ DEF 14A 2025HRTX DEF 14A 2025: proxy statement for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ DEF 14A 2024HRTX DEF 14A 2024: proxy statement for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ DEF 14A 2023HRTX DEF 14A 2023: proxy statement for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ DEF 14A 2022HRTX DEF 14A 2022: proxy statement for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ Form 4 2026HRTX Form 4 2026: insider trading filing for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ Form 4 2025HRTX Form 4 2025: insider trading filing for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ Form 4 2024HRTX Form 4 2024: insider trading filing for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ Form 4 2023HRTX Form 4 2023: insider trading filing for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ Form 4 2022HRTX Form 4 2022: insider trading filing for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ S-1 2026HRTX S-1 2026: registration statement for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ S-1 2025HRTX S-1 2025: registration statement for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ S-1 2024HRTX S-1 2024: registration statement for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ S-1 2023HRTX S-1 2023: registration statement for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ S-1 2022HRTX S-1 2022: registration statement for fiscal 2022
- HERON THERAPEUTICS, INC. /DE/ 13F 2026HRTX 13F 2026: institutional holdings for fiscal 2026
- HERON THERAPEUTICS, INC. /DE/ 13F 2025HRTX 13F 2025: institutional holdings for fiscal 2025
- HERON THERAPEUTICS, INC. /DE/ 13F 2024HRTX 13F 2024: institutional holdings for fiscal 2024
- HERON THERAPEUTICS, INC. /DE/ 13F 2023HRTX 13F 2023: institutional holdings for fiscal 2023
- HERON THERAPEUTICS, INC. /DE/ 13F 2022HRTX 13F 2022: institutional holdings for fiscal 2022
More companies